CVSA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 41 instances where the indicator turned negative. In 30 of the 41 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 73%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CVSA as a result. In 55 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.
CVSA moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CVSA crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVSA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CVSA's RSI Indicator exited the oversold zone, 17 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 48 cases where CVSA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
Following a +4.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVSA advanced for three days, in 292 of 389 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
CVSA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 184 of 269 cases where CVSA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. CVSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.597) is normal, around the industry mean (1.158). P/E Ratio (15.365) is within average values for comparable stocks, (8.484). Projected Growth (PEG Ratio) (0.866) is also within normal values, averaging (1.327). Dividend Yield (0.000) settles around the average of (4.152) among similar stocks. P/S Ratio (2.325) is also within normal values, averaging (27.566).
UTI saw its Momentum Indicator move below the 0 level on November 20, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned negative. In 75 of the 97 cases, the stock moved further down in the following days. The odds of a decline are at 77%.
The Moving Average Convergence Divergence Histogram (MACD) for UTI turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 34 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
UTI moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The RSI Indicator entered the oversold zone -- be on the watch for UTI's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for UTI crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +16.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where UTI advanced for three days, in 259 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
UTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 180 of 250 cases where UTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 74 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. UTI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: UTI's P/B Ratio (3.189) is slightly higher than the industry average of (1.158). UTI has a moderately high P/E Ratio (32.145) as compared to the industry average of (8.484). Projected Growth (PEG Ratio) (1.642) is also within normal values, averaging (1.327). Dividend Yield (0.004) settles around the average of (4.152) among similar stocks. P/S Ratio (1.320) is also within normal values, averaging (27.566).
CVSA | UTI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 56 | 88 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 35 | 74 | |
SMR RATING 1..100 | 51 | 68 | |
PRICE GROWTH RATING 1..100 | 60 | 78 | |
P/E GROWTH RATING 1..100 | 38 | 10 | |
SEASONALITY SCORE 1..100 | 50 | 14 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVSA's Valuation (74) in the Other Consumer Services industry is in the same range as UTI (85) in the Miscellaneous Commercial Services industry. This means that CVSA’s stock grew similarly to UTI’s over the last 12 months.
CVSA's Profit vs Risk Rating (35) in the Other Consumer Services industry is somewhat better than the same rating for UTI (74) in the Miscellaneous Commercial Services industry. This means that CVSA’s stock grew somewhat faster than UTI’s over the last 12 months.
CVSA's SMR Rating (51) in the Other Consumer Services industry is in the same range as UTI (68) in the Miscellaneous Commercial Services industry. This means that CVSA’s stock grew similarly to UTI’s over the last 12 months.
CVSA's Price Growth Rating (60) in the Other Consumer Services industry is in the same range as UTI (78) in the Miscellaneous Commercial Services industry. This means that CVSA’s stock grew similarly to UTI’s over the last 12 months.
UTI's P/E Growth Rating (10) in the Miscellaneous Commercial Services industry is in the same range as CVSA (38) in the Other Consumer Services industry. This means that UTI’s stock grew similarly to CVSA’s over the last 12 months.
| CVSA | UTI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 89% | 2 days ago 86% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 66% | 2 days ago 77% |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 70% |
| TrendMonth ODDS (%) | 2 days ago 54% | 2 days ago 66% |
| Advances ODDS (%) | 11 days ago 75% | 12 days ago 78% |
| Declines ODDS (%) | 2 days ago 63% | 2 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 82% | 2 days ago 82% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 72% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVSA’s FA Score shows that 0 FA rating(s) are green while UTI’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVSA’s TA Score shows that 5 TA indicator(s) are bullish while UTI’s TA Score has 6 bullish TA indicator(s).
CVSA (@Other Consumer Specialties) experienced а -7.65% price change this week, while UTI (@Other Consumer Specialties) price change was -21.92% for the same time period.
The average weekly price growth across all stocks in the @Other Consumer Specialties industry was -2.01%. For the same industry, the average monthly price growth was -18.87%, and the average quarterly price growth was -22.43%.
CVSA is expected to report earnings on Feb 02, 2027.
UTI is expected to report earnings on Feb 10, 2027.
‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.
A.I.dvisor indicates that over the last year, CVSA has been loosely correlated with PRDO. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if CVSA jumps, then PRDO could also see price increases.
| Ticker / NAME | Correlation To CVSA | 1D Price Change % | ||
|---|---|---|---|---|
| CVSA | 100% | -5.52% | ||
| PRDO - CVSA | 66% Loosely correlated | -2.90% | ||
| LOPE - CVSA | 65% Loosely correlated | -2.78% | ||
| STRA - CVSA | 63% Loosely correlated | -4.20% | ||
| APEI - CVSA | 56% Loosely correlated | -2.62% | ||
| LAUR - CVSA | 54% Loosely correlated | -1.32% | ||
More | ||||
A.I.dvisor indicates that over the last year, UTI has been loosely correlated with LINC. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if UTI jumps, then LINC could also see price increases.
| Ticker / NAME | Correlation To UTI | 1D Price Change % | ||
|---|---|---|---|---|
| UTI | 100% | -14.87% | ||
| LINC - UTI | 66% Loosely correlated | -7.71% | ||
| AZZ - UTI | 49% Loosely correlated | -4.58% | ||
| APEI - UTI | 48% Loosely correlated | -2.62% | ||
| CVSA - UTI | 47% Loosely correlated | -5.52% | ||
| PRDO - UTI | 46% Loosely correlated | -2.90% | ||
More | ||||